Promega
| Company type | Private |
|---|---|
| Industry | Biotechnology |
| Founded | 1978 |
| Founder | Bill Linton |
| Headquarters | Madison, Wisconsin , United States |
Area served | Worldwide (over 100 countries) |
| Products | Enzymes, molecular biology products, genomics tools, protein expression and analysis products, cellular assays, drug discovery tools, genetic identification kits |
| Owner | Private ownership |
Number of employees | 1,601 (2019) |
| Website | www |
Promega Corporation is a manufacturer headquartered in Madison, Wisconsin that specializes in producing enzymes and various products for molecular biology and biotechnology applications. Its range of offerings covers areas such as genomics, protein expression and analysis, cellular assays, drug discovery, and genetic identification.
History
Established in 1978 by Bill Linton with the initial goal of supplying restriction enzymes for the biotechnology sector, Promega has since expanded its catalog to include more than 4,000 life science products utilized by researchers and pharmaceutical firms. The privately owned enterprise employs approximately 1,601 staff members and reported revenues close to $450 million (USD) in 2019.
With branch locations in 16 countries and collaborations with over 50 distributors globally, Promega serves customers in more than 100 nations. A notable milestone was its creation of the first biotechnology joint venture in China—Sino-American Biotechnology Co.—in 1985, demonstrating its early commitment to international growth.
Promega developed an RFID-based inventory management system designed for remote site stocking, which led to the establishment of Terso Solutions, a company focused on manufacturing compact RFID-enabled storage units.
In recent years, the company has come under examination for continuing to sell equipment to the Xinjiang Production and Construction Corps despite existing export limitations. Investigations from 2020 and 2021 disclosed ongoing transactions involving its DNA analysis instruments to law enforcement agencies in Xinjiang, prompting questions about regulatory adherence and ethical responsibilities within its global business practices.
Genomics
Originally centered on genomics research tools, Promega's product line now encompasses cloning systems, luciferase reporter assays, and nucleic acid amplification kits alongside its foundational restriction and modifying enzymes. Prominent amplification products include GoTaq polymerases with their respective buffers as well as the Plexor quantitative PCR platform.
Genetic identity and forensics
Promega is recognized as a leading provider of genetic identification solutions that utilize DNA analysis through short tandem repeats (STRs). It pioneered the introduction of kits targeting single-locus STR analysis. In partnership with Applied Biosystems, the FBI, and forensic laboratories, Promega contributed to the validation of STR markers used in the Combined DNA Index System (CODIS), a critical component for forensic DNA profiling across North America. The company's PowerPlex STR kits were the first commercial products to incorporate all CODIS loci.
Proteomics
Having been an early entrant into cell-free protein synthesis technologies, Promega continues to broaden its offerings within the proteomics field.
Integrated platforms
The firm markets automated purification platforms such as the Maxwell RSC and Maxwell RSC 48 Systems—compact bench-top instruments designed for low- to medium-throughput research and diagnostic laboratories. Furthermore, its Y-Chromosome Deletion Detection System has obtained CE Mark certification as an in vitro diagnostic device within the European Union.